Bharat Parenterals Limited (BPLPHARMA) reported revenue of ₹55.50 Cr and net profit of ₹3.66 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from Bharat Parenterals Limited’s filed results, 6 filed quarters and 12 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 5, 2026
| ₹ Cr | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|
| Sales | 80.3 | 94.4 | 41.7 | 41.4 | 56.5 | 55.5 | -41.2% |
| 75.7 | 79.1 | 39.4 | 37.9 | 56.5 | 48.7 | -38.5% | |
| Operating profit | 4.60 | 15.3 | 2.34 | 3.47 | 0.03 | 6.83 | -55.3% |
| OPM % | 5.7% | 16.2% | 5.6% | 8.4% | 0.1% | 12.3% | -3.9 pp |
| Other income | 2.26 | 1.62 | 4.21 | 2.28 | 4.44 | 1.05 | -35.0% |
| Interest | 1.48 | 1.42 | 0.96 | 0.55 | 0.51 | 0.69 | -51.2% |
| Depreciation | 1.82 | 2.06 | 2.17 | 2.10 | 2.04 | 2.26 | +9.5% |
| Profit before tax | 3.56 | 13.4 | 3.42 | 3.10 | 1.93 | 4.93 | -63.2% |
| Tax % | 30.9% | 25.4% | 20.2% | 38.2% | 28.5% | 25.8% | +0.5 pp |
| Net profit | 2.28 | 10.0 | 2.73 | 1.92 | 1.38 | 3.66 | -63.4% |
| EPS (₹) | 3.48 | 14.51 | 3.96 | 2.78 | 2.00 | 5.31 | -63.4% |
